January 16, 2018Open Access

Thymic stromal lymphopoietin drives the development of IL-13 + Th2 cells

SOSotaro OchiaiMalaghan Institute of Medical Research FJFerdinand JagotCentre National de la Recherche Scientifique RKRyan KylePsiOxus Therapeutics (United Kingdom)

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

Our findings suggest a role of TSLP in directly promoting Th2 cell effector function and support the notion of TSLP as a key driver of Th2 inflammation.

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo

Cite This Study

Ochiai et al. (Tue,) studied this question.

synapsesocial.com/papers/69ff952ee4618ba4162d83da https://doi.org/https://doi.org/10.1073/pnas.1714348115

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Inhibition of Th2 Differentiation and GATA-3 Expression by BCL-62003 · 163 citations
2Topical vitamin D3 and low-calcemic analogs induce thymic stromal lymphopoietin in mouse keratinocytes and trigger an atopic dermatitis2006 · 536 citations
3Type 2 cytokines: mechanisms and therapeutic strategies2015 · 693 citations
4TSLP Produced by Keratinocytes Promotes Allergen Sensitization through Skin and Thereby Triggers Atopic March in Mice2012 · 228 citations
5TSLP-activated dendritic cells induce human T follicular helper cell differentiation through OX40-ligand2017 · 162 citations

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo